Protect Pharmaceutical Corp. (PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger
Protect Pharmaceutical Corp. (OTC: PRTT) has announced significant changes in its leadership and a pending merger with Karinca Logistics. Ozgur Ozcan has been appointed as the new CEO and Director, while George Athanasiadis joins as a Director. These appointments come alongside the resignations of Ali Yildiz as CEO and Tatiana Aleinikov as VP of Operations.
The company is in the final stages of merging with Karinca Logistics, a move expected to boost revenue and profitability. PRTT plans to provide shareholders with an update on the merger and pending audit within a week. The company also intends to file a Form 10 registration with the SEC to resume reporting standards and aims to uplist to an exchange. A company name change is also in the works to better reflect its current business focus.
Protect Pharmaceutical Corp. (OTC: PRTT) ha annunciato cambiamenti significativi nella sua leadership e una fusione in fase di completamento con Karinca Logistics. Ozgur Ozcan è stato nominato nuovo CEO e Direttore, mentre George Athanasiadis entra come Direttore. Queste nomine avvengono insieme alle dimissioni di Ali Yildiz come CEO e di Tatiana Aleinikov come VP delle Operazioni.
La società è nelle fasi finali della fusione con Karinca Logistics, un'operazione che si prevede migliorerà i ricavi e la redditività. PRTT prevede di fornire agli azionisti un aggiornamento sulla fusione e sull'audit in corso entro una settimana. L'azienda ha anche intenzione di presentare un modulo di registrazione 10 alla SEC per riprendere gli standard di reporting e mira a passare a un altro mercato. È anche in programma un cambiamento del nome dell'azienda per riflettere meglio il suo attuale focus commerciale.
Protect Pharmaceutical Corp. (OTC: PRTT) ha anunciado cambios significativos en su liderazgo y una fusión pendiente con Karinca Logistics. Ozgur Ozcan ha sido nombrado como nuevo CEO y Director, mientras que George Athanasiadis se une como Director. Estos nombramientos se producen junto con las renuncias de Ali Yildiz como CEO y Tatiana Aleinikov como VP de Operaciones.
La empresa se encuentra en las etapas finales de fusión con Karinca Logistics, un movimiento que se espera aumente los ingresos y la rentabilidad. PRTT planea proporcionar a los accionistas una actualización sobre la fusión y la auditoría pendiente dentro de una semana. La compañía también tiene la intención de presentar un formulario de registro 10 ante la SEC para reanudar los estándares de informes y busca listar sus acciones en una bolsa. También se está considerando un cambio de nombre de la empresa para reflejar mejor su enfoque comercial actual.
Protect Pharmaceutical Corp. (OTC: PRTT)는 리더십에 중대한 변화를 선언하고 Karinca Logistics와의 합병을 앞두고 있습니다. Ozgur Ozcan이 새로운 CEO 및 이사로 임명되었으며, George Athanasiadis가 이사로 합류했습니다. 이번 임명은 Ali Yildiz CEO와 Tatiana Aleinikov 운영 부사장의 사임과 함께 이루어졌습니다.
회사는 현재 Karinca Logistics와의 합병을 막바지 단계에 이르렀으며, 이는 수익과 수익성을 증대시킬 것으로 예상됩니다. PRTT는 주주들에게 합병 및 진행중인 감사에 대한 업데이트를 일주일 이내에 제공할 계획입니다. 이 회사는 SEC에 Form 10 등록을 제출하여 보고 기준을 재개할 계획이며, 다른 거래소로의 상장도 목표로 하고 있습니다. 또한 현재의 사업 초점을 더 잘 반영하기 위해 회사 이름 변경이 계획되고 있습니다.
Protect Pharmaceutical Corp. (OTC: PRTT) a annoncé des changements significatifs au sein de sa direction et une fusion imminente avec Karinca Logistics. Ozgur Ozcan a été nommé nouveau PDG et Directeur, tandis que George Athanasiadis rejoint le conseil en tant que Directeur. Ces nominations interviennent en parallèle avec les démissions de Ali Yildiz en tant que PDG et de Tatiana Aleinikov en tant que VP des Opérations.
La société est dans les dernières étapes de sa fusion avec Karinca Logistics, un mouvement qui devrait augmenter les revenus et la rentabilité. PRTT prévoit de fournir aux actionnaires une mise à jour sur la fusion et l'audit en cours dans une semaine. L'entreprise envisage également de déposer un formulaire 10 auprès de la SEC pour reprendre ses obligations de reporting et vise à être listée sur une bourse. Un changement de nom de l'entreprise est également prévu pour mieux refléter son orientation commerciale actuelle.
Protect Pharmaceutical Corp. (OTC: PRTT) hat bedeutende Veränderungen in der Unternehmensführung und eine bevorstehende Fusion mit Karinca Logistics angekündigt. Ozgur Ozcan wurde als neuer CEO und Direktor ernannt, während George Athanasiadis als Direktor hinzukommt. Diese Ernennungen erfolgen parallel zu den Rücktritten von Ali Yildiz als CEO und Tatiana Aleinikov als VP für Operations.
Das Unternehmen befindet sich in den finalen Phasen der Fusion mit Karinca Logistics, eine Maßnahme, die voraussichtlich Umsatz und Rentabilität steigern wird. PRTT plant, den Aktionären innerhalb einer Woche ein Update zur Fusion und zur laufenden Prüfung zu geben. Das Unternehmen beabsichtigt außerdem, ein Formblatt 10 bei der SEC einzureichen, um die Berichtstandards wieder aufzunehmen, und strebt an, an eine Börse aufzulisten. Eine Namensänderung des Unternehmens ist ebenfalls in Planung, um den aktuellen Geschäftsfokus besser widerzuspiegeln.
- Appointment of new CEO and Director to facilitate merger
- Pending merger with Karinca Logistics expected to increase revenue and profitability
- Plans to file Form 10 registration with SEC and uplist to an exchange
- Intention to resume reporting standards, improving transparency
- Resignations of previous CEO and VP of Operations
- Pending merger and audit results create short-term uncertainty
ANKARA, Turkey, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp. (OTC: PRTT) ("Company") announces the appointment of a new CEO, restructuring of the Board of Directors, and looks to finalize the merger agreement with Karinca Logistics - www.karincalogistics.com.
The Company appointed Ozgur Ozcan as CEO and Director and George Athanasiadis as Director. Further, the Company accepted the resignations of Ali Yildiz as CEO and Tatiana Aleinikov as VP of Operations.
The Board restructuring and the appointment of the new CEO are the first steps to ensure a smooth transition with the merger, which should be finalized in the next few days in Turkey.
Ozgur Ozcan, PRTT's CEO, stated, "This is an exciting time for the Company. I look forward to working towards our goals within the Company. I will provide shareholders with an update regarding the finalization of the merger and our pending audit within the next week. We intend to complete the process as formerly announced and file a Form 10 registration with the SEC to resume reporting standards and eventually uplist the Company to an exchange. It is also our intention to change the name of the Company to a more appropriate name for our current business."
Management believes the merger of Atlantic Logistics and Karinca Logistics will solidify its regional competitive advantage and unite two (2) compelling companies into one management group. The Company expects a large growth in revenue and profitability upon finalizing the merger.
About Atlantic Logistics:
Atlantic Logistics strives to provide innovation in service, a business model that gives customers and partners the technology and commercial intelligence to support creative ideas. The team remains dedicated to keeping the company’s systems on the cutting edge and constantly evolving business to serve our clients better. Atlantic Logistics use robust technology to track inventories, manage customs compliance, and track shipments worldwide. Atlantic Logistics is the answer to any logistics needs you might have. Atlantic Logistics transports products via land, air, and sea using trucks, ships, rail, and air, rapidly growing into a worldwide logistics company with services across Europe, Asia, South America, and Central America - www.atlantic-logistics.net.
Forward-Looking Statements:
This press release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "plan", "expect", "believe", "anticipate", "intend", "could", "would", "estimate," or "continue", or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information contact:
Protect Pharmaceutical Corp.
Ozgur Ozcan +90 (554) 112 40 25
Info@atlantic-logistics.net
www.atlantic-logistics.net
FAQ
Who is the new CEO of Protect Pharmaceutical Corp. (PRTT)?
What major corporate action is PRTT currently undertaking?
What are PRTT's plans for improving its market position?
How is the merger with Karinca Logistics expected to impact PRTT?
